Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval ...

Salipro Biotech AB, a Swedish biotech company specialising in the stabilisation of challenging drug targets, today announced a research and license agreement with ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until ...

The latest HPRA inspection in February 2025 was highly successful-both QC licences were renewed, and viral vector manufacturing was added to the MIA (IMP) licence. This means the Shannon site can ...

The deal gives the Swiss pharma access to an experimental amylin-targeting treatment it will test in combination with drugs ...

On Day 12 of the “war against drugs”, the Punjab Police on Wednesday conducted raids at 543 locations, leading to the arrest ...

YOUNGSTOWN, Ohio (WKRC) - Authorities allegedly caught a woman hiding in a cardboard box while searching for drugs in an Ohio ...

A 46-year-old man with no permanent address faces drug charges after a Jan. 27 traffic stop in Onalaska. Robert L. Perry was ...

The new pill is the first long-term daily pill licensed to treat the condition, and works by blocking specific hormones that ...

Empagliflozin, which in addition to treating type-2 diabetes, also aids weight loss, and reduces cardiovascular and kidney ...

Affecting up to 10% of women of reproductive age, endometriosis is a painful condition caused by tissue normally found lining ...